| Literature DB >> 23795338 |
Christian Maurer1, Ernst Pittenauer, Michael Puchberger, Günter Allmaier, Ulrich Schubert.
Abstract
The treatment of titanium alkoxides withEntities:
Keywords: alkoxides; bridging ligands; mass spectrometry; structure elucidation; titanium
Year: 2013 PMID: 23795338 PMCID: PMC3688322 DOI: 10.1002/cplu.201300014
Source DB: PubMed Journal: Chempluschem ISSN: 2192-6506 Impact factor: 2.863
Scheme 1The structures of [(Ti{OiPr}2{bis(diketonate)})2] (above left, various groups X), [Ti(OiPr)2{bis(salicylaldiminate)}] (below left), and [Ti4(OiPr)8(ON=CMe–CH2–CMe=NO)4] (right).
Scheme 2Numbering scheme of the prepared compounds.
Figure 3Positive-ion ESI mass spectrum (top) and low-energy CID (MS/MS) spectrum (bottom) of [{TiL(OEt)2}2] (2).
Figure 1Molecular structure of [{TiL(OiPr)2}2] (1). The hydrogen atoms were omitted for clarity. Selected bond lengths [pm] and angles [°]: Ti1–O1 204.6(3), Ti1–O2 203.0(3), Ti1–O3 196.5(3), Ti1–O5 195.4(3), Ti1–O7 179.9(4), Ti1–N1 203.2(4), Ti1–N4 216.9(4), O1–Ti1–O2 74.92(1), Ti2–O1 203.8(3), Ti2–O2 206.2(2), Ti2–O4 192.3(4), Ti2–O6 196.3(3), Ti2–O8 181.2(3), Ti2–N2 214.5(4), Ti2–N3 206.1(4), O1–Ti2–O2 74.41(1), O1–Ti1–O7 91.75(1), O2–Ti1–O7 166.67(1), O3–Ti1–O7 98.56(1), O3–Ti1–O5 85.40(1), O5–Ti1–O7 97.94(2), N1–Ti1–N4 161.23(1), O1–Ti2–O8 92.80(1), O2–Ti2–O8 166.19(2), O4–Ti2–O6 86.54(1), O4–Ti2–O8 93.88(1), O6–Ti2–O8 97.00(1), N2–Ti2–N3 162.89(1).
Figure 2Molecular structure of [{TiL(OEt)2}2] (3). The hydrogen atoms were omitted for clarity. The asterisk denotes inversion-related atoms. Selected bond lengths [pm] and angles [°]: Ti1–O1 195.63(14), Ti1–O2 204.75(13), Ti1–O2* 202.78(13), Ti1–O4 180.68(14), Ti1–O11 195.30(14), Ti1–N3 209.0(2), Ti1–N4 209.2(2), O1–Ti1–O4 98.09(6), O1–Ti1–O11 85.67(7), O2–Ti1–O2* 71.61(6), O2–Ti1–O4 92.07(6), O2*–Ti1–O4 162.46(6), O4–Ti1–O11 100.09(6), N3–Ti1–N4 164.48(7).
Scheme 3Two structure types of compounds [{TiL(OR)2}2] (L=bridging bifunctional ligand with chelating groups A–B).
Figure 4EXSY spectrum of 1 in the CH region at (a) room temperature and (b) −60 °C.
Figure 5Possible mechanism of active OiPr exchange in 1.
Figure 6Temperature-dependent 1H NMR spectra of 1.
Figure 7Positive-ion ESI mass spectrum (top) and low-energy CID (MS/MS) spectrum (bottom) of [{TiL(OiPr)2}2] (6).
Crystallographic parameters of 1 and 3
| 1 | 3 | |
|---|---|---|
| formula | C24H48N4O8Ti2 | C18H36N4O8Ti2 |
| 616.6 | 532.3 | |
| 100 | 100 | |
| crystal system | monoclinic | monoclinic |
| space group | ||
| 989.40(9) | 1548.15(5) | |
| 3062.1(3) | 1167.11(4) | |
| 1072.13(9) | 1363.70(5) | |
| 106.4530(10) | 96.862(2) | |
| 3115.2(5) | 2446.37(15) | |
| 4 | 4 | |
| 1.314 | 1.445 | |
| 0.560 | 0.701 | |
| crystal size [mm] | 0.40×0.40×0.20 | 0.43×0.31×0.19 |
| 1.33–24.98 | 1.32–30.62 | |
| reflns collected/unique | 8442/4492 | 26 049/7522 |
| data/parameters | 4492/355 | 7522/293 |
| GOF on | 0.712 | 0.703 |
| 0.045 | 0.042 | |
| 0.144 | 0.113 | |
| largest diff. peak/hole [e Å−3] | 0.540/−0.445 | 0.653/−0.975 |